Previous studies have shown that BRG1 is required to enable the expression of CD44 in tumor cells as well as to provide a mechanism for the activation of CD44 expression depending on the chromatin remodeling activity mediated by BRG1 [24]. Here, SMARCA4 is linked to neoplasm.